Morpholine-4-carboxamide → HCID 15885815, compound

HRID 843700Notes

Reaction equation

HRID 843700 reaction equation
[CH3:1][C:2]([CH3:35])([O:4][C:5]([NH:7][CH2:8][C:9]1[CH:10]=[CH:11][C:12]2[N:17]=[C:16]([NH:18][C@H:19]([C:29](O)=[O:30])[CH2:20]C3C=CC(OC)=CC=3)[O:15][C:14](=[O:32])[C:13]=2[C:33]=1[CH3:34])=[O:6])[CH3:3].[N:36]1(C(N)=O)[CH2:41]COC[CH2:37]1>>[CH3:37][N:36]([CH3:41])[C:29](=[O:30])[C@H:19]([CH3:20])[NH:18][C:16]1[O:15][C:14](=[O:32])[C:13]2[C:33]([CH3:34])=[C:9]([CH2:8][NH:7][C:5]([O:4][C:2]([CH3:3])([CH3:1])[CH3:35])=[O:6])[CH:10]=[CH:11][C:12]=2[N:17]=1

Participants

3

Procedure

N-[6-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-5-methyl-4-oxo-4H-3,1-benzoxazin-2-yl]-O-methyl-L-tyrosine, morpholineamide;

Sources & evidence

ORD record
ord-353ddd9872d448a9a34187c51deab3cf
Source dataset
uspto-grants-2002_04
Patent number
US06380189B1

Reaction notes

Loading…